Category: Corona Virus Vaccine

Page 252«..1020..251252253254..260270..»

Fauci wants people to know that one of lead scientists who developed the Covid-19 vaccine is a Black woman – CNN

December 10, 2020

The nation's top infectious disease expert, speaking at an event hosted by the National Urban League on Tuesday, said it was important to acknowledge the US history of racism in medical research and understand how that has fostered mistrust among some Black people.

But Fauci stressed that the upcoming Covid-19 vaccines are safe and effective, adding that African American scientists have been involved in their development.

"The very vaccine that's one of the two that has absolutely exquisite levels -- 94 to 95% efficacy against clinical disease and almost 100% efficacy against serious disease that are shown to be clearly safe -- that vaccine was actually developed in my institute's vaccine research center by a team of scientists led by Dr. Barney Graham and his close colleague, Dr. Kizzmekia Corbett, or Kizzy Corbett," Fauci said.

"So, the first thing you might want to say to my African American brothers and sisters is that the vaccine that you're going to be taking was developed by an African American woman," Fauci added. "And that is just a fact."

Experts are trying to build confidence

But skepticism among some people of color, especially Black Americans, remains high.

Corbett told CNN's Dr. Sanjay Gupta that she sees vaccine hesitancy in Black communities firsthand. Rebuilding trust in medical institutions will take time, she said, and that's something that health experts have to accept.

For her part, Corbett said she is trying to help earn back that trust.

"Trust, especially when it has been stripped from people, has to be rebuilt in a brick-by-brick fashion," she said. "And so, what I say to people firstly is that I empathize, and then secondly is that I'm going to do my part in laying those bricks. And I think that if everyone on our side, as physicians and scientists, went about it that way, then the trust would start to be rebuilt."

Fauci addresses specific concerns

Fauci is taking a similar approach.

He said he generally hears two major concerns about the vaccines: the speed at which they were developed, and their safety and efficacy.

He also addressed concerns that pharmaceutical companies or the federal government couldn't be trusted to assess the safety of the vaccine, saying that both are advised by independent committees made up of experienced clinicians, scientists and ethicists.

Those independent experts, not politicians, determine whether the vaccine is safe for the public, he added.

"When they then say that the vaccine is safe and effective, I will tell you all that I, myself, will be perfectly comfortable in taking the vaccine and I will recommend it to my family," Fauci said.

CNN's Nicquel Terry Ellis, Sanjay Gupta and Shelby Lin Erdman contributed to this report.

See more here:

Fauci wants people to know that one of lead scientists who developed the Covid-19 vaccine is a Black woman - CNN

These Stocks Have The Most To Gain From Covid-19 Vaccine-Making And Distribution, According To Bank Of America – Forbes

December 10, 2020

Topline

A slew of publicly traded firms along the vaccine supply chain are set to cash in as widespread inoculation kicks into high gear in the coming weeks; here are some of the firms set to profit the most from vaccine-making and distribution, according to a Bank of America note sent to clients on Wednesday.

A phial of the Pfizer/BioNTech COVID-19 vaccine ready for administration at Guy's Hospital at the ... [+] start of the largest ever immunization program in the UK's history on December 8.

On the manufacturing front, Thermo Fisher Scientific, Merck and Avantor are among five firms set to see an overall sales boost of at least 15% each, thanks to their bioprocessing research work, with combined revenue potential of as much as $10 billion, Bank of America estimates.

Meanwhile, Pennsylvania-based West Pharmaceutical, the maker of rubber stoppers used for vaccine packaging, should lead gains in its industry, analysts forecast, with a more than 15% increase in profit, which last year totaled $242 million.

Sales opportunities in distribution are highest for Hong Kong-based airline Cathay Pacific due to its freight exposure and partnership with couriers like FedEx, UPS and DHL; Bank of America estimates the firm could see $640 million (HKD 5 billion) in revenue potential next year from transporting coronavirus vaccine doses.

In the United States, FedEx and UPS are estimated to see domestic revenues rise between $100 million to $300 million apiece for their vaccine distribution efforts, but that's a pittance relative to overall annual revenues of roughly $20 billion each.

The outlook for refrigerated storage providers is still difficult to quantify, Bank of America notes, but engineering giants Emerson Electric and Trane Technologies could see revenue boosts of $1.3 billion and $2 billion, respectively, while Arkema and Thermo Fisher also have leading exposure in this market.

CVS Health and Walgreens Boots Alliancethe nation's two largest drugstore chainsare best positioned in retail to benefit from onsite vaccinations, but the degree to which that impacts financials is contingent on the percentage of doses given in retail settings, as opposed to medical, which is still very uncertain, the bank says.

"The billions of syringes, millions of drugstore visits and thousands of flights don't always translate to profit bonanzas for the companies in the vaccine supply chain, but we do anticipate significant benefits for some companies, especially those enabling vaccine manufacturing and those transporting the vaccine in Asia and Europe," Bank of America analysts said on Wednesday.

Widespread vaccination is just getting started. On Tuesday, a 90-year-old woman became the western world's first recipient of a clinically approved Covid-19 vaccine, one of the Pfizer-BioNTech vaccines approved for emergency use in the United Kingdom last week. The nation's government has already ordered 40 million of those doses, enough to vaccinate 20 million people. Meanwhile, the United States, whose population of 330 million is roughly five times greater than the United Kingdom's, has only ordered enough vaccines to inoculate 50 million people.

Bank of America biopharmaceutical analysts forecast roughly 200 million healthcare workers and elderly people will receive vaccines from either Moderna or Pfizer and BioNTech "over the coming months" following their emergency use authorizations in the United States, Europe and Japan. By the second half of next year, everyone in these three markets who wants a vaccine should be able to receive one, the bank predicts.

1.65 billion. That's the number of global coronavirus vaccine doses Bank of America analysts forecast will be distributed in 2021, just a fraction of the several billion doses vaccine-makers are currently estimating they'll produce.

Shares of top Covid-19 vaccine candidate makers Pfizer, BioNTech and Moderna have surged an eye-popping 13%, 220% and 720% this year.

V-Day: U.K. Kicks Off Western Worlds First Covid-19 Vaccination Campaign (Forbes)

The U.S. Has Ordered Enough Of Pfizers Covid-19 Vaccine For 50 Million PeopleBut Thats All (Forbes)

Trump Signs Executive Order Prioritizing U.S. For Covid Vaccine But Its Unclear Whether It Accomplishes Anything (Forbes)

Read the original post:

These Stocks Have The Most To Gain From Covid-19 Vaccine-Making And Distribution, According To Bank Of America - Forbes

Hillsborough to survey residents for their views on coronavirus vaccines – Tampa Bay Times

December 10, 2020

TAMPA Hillsborough County wants to gauge public sentiment on COVID-19 vaccines and learn whether there are obstacles that could prevent county residents from receiving a vaccine.

An anonymous survey, offered in English and Spanish, is intended to help county leaders understand public attitudes and trepidations about the COVID-19 vaccines. The survey results will help the county plan distribution logistics and public awareness campaigns to maximize the number of residents who choose to get vaccinated, the county said in a released statement.

To participate, visit the countys Web site at HCFLGov.net/COVIDVaccine. To take the survey via text, text the word vaccine to 73224 or text Vacuna to 73224 to take the survey in Spanish.

The survey includes a brief video on vaccine development. Afterward, questions will focus on respondents: Level of exposure to COVID-19; attitudes about getting vaccinated; motivations to receive the vaccine or remain unvaccinated; potential changes in behavior after being vaccinated and preferred geographic locations where the vaccinations could be offered.

The county previously used anonymous surveys to guide communications in offering COVID-19 resources, including testing and safety protocols.

Among the findings in that survey, conducted by HCP Associates and Hillsborough County in April, was that three-quarters of Hillsborough County residents were serious about wearing face coverings in public during the coronavirus outbreak.

HOW CORONAVIRUS IS SPREADING IN FLORIDA: Find the latest numbers for your county, city or zip code.

FACE MASKS: Read the latest on guidelines, tips for comfort and long-term wear

GET THE DAYSTARTER MORNING UPDATE: Sign up to receive the most up-to-date information.

THE CORONAVIRUS SCRAPBOOK: We collected your stories, pictures, songs, recipes, journals and more to show what life has been like during the pandemic.

A TRIBUTE TO THE FLORIDIANS TAKEN BY THE CORONAVIRUS: They were parents and retirees, police officer and doctors, imperfect but loved deeply.

HAVE A TIP?: Send us confidential news tips

Were working hard to bring you the latest news on the coronavirus in Florida. This effort takes a lot of resources to gather and update. If you havent already subscribed, please consider buying a print or digital subscription.

Read more here:

Hillsborough to survey residents for their views on coronavirus vaccines - Tampa Bay Times

Vaccine Approval Looks Imminent, But Distrust, Misinformation Have Experts Worried : Consider This from NPR – NPR

December 10, 2020

The Food and Drug Administration has found that there are "no specific safety concerns" that would stop the agency from approving the COVID-19 vaccine made by Pfizer and BioNTech for emergency use. Sarah Silbiger/Getty Images hide caption

The Food and Drug Administration has found that there are "no specific safety concerns" that would stop the agency from approving the COVID-19 vaccine made by Pfizer and BioNTech for emergency use.

The Food and Drug Administration could vote as soon as Thursday to approve a COVID-19 vaccine developed by Pfizer for emergency use authorization in the United States.

Speaking to NPR this week, FDA head Dr. Stephen Hahn reiterated the government's commitment to vaccine safety. But public opinion polls suggest many Americans are still skeptical of coronavirus vaccines, and misinformation about them has been spreading online.

Renee DiResta of the Stanford Internet Observatory tells NPR why misinformation often takes hold where people are not necessarily looking for it.

NPR's Adrian Florido reports public health experts are worried that Latinos and African Americans communities that are disproportionately affected by COVID-19 may be less likely to get vaccinated.

In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.

Email us at considerthis@npr.org.

This episode was produced by Brianna Scott, Lee Hale and Brent Baughman, with additional reporting by Shannon Bond. It was edited by Sami Yenigun with help from Emily Kopp. Our executive producer is Cara Tallo.

Go here to see the original:

Vaccine Approval Looks Imminent, But Distrust, Misinformation Have Experts Worried : Consider This from NPR - NPR

Illinois endures its fifth-highest daily death count ahead of coronavirus vaccines expected arrival (LIVE UP – Chicago Sun-Times

December 10, 2020

Mayor Lori Lightfoot outlined her plan for distributing coronavirus vaccines in Chicago Wednesday, and theyll be free to all adults working or living in the city.

Heres what else happened in coronavirus-related news.

Days ahead of the Pfizer coronavirus vaccines expected arrival in Illinois, the state endured its fifth-highest daily death count of the pandemic Wednesday with public health officials announcing COVID-19 has claimed 179 more lives.

And while the average statewide infection rate has fallen to its lowest point in almost five weeks, Illinois hospitals saw their biggest one-day jump in coronavirus patients since reaching an all-time high before Thanksgiving.

The latest fatalities reported by the Illinois Department of Public Health included 61 Cook County residents and 27 more from elsewhere across the Chicago area.

The daily toll of 179 trails only the spring peak of 191 and the three worst days of the pandemic, all of which have been tallied over the last week capped by the grisly record of 238 COVID-19 deaths reported Dec. 2.

The respiratory disease has claimed 13,666 Illinois lives since early March about 52 lives lost each day. At least 812,430 people have contracted the virus over the past nine months.

WASHINGTON Still spinning their wheels on COVID-19 relief, lawmakers grabbed a one-week government funding extension on Wednesday that buys time for more talks though there is considerable disagreement over who is supposed to be taking the lead from there.

Amid the uncertainty, the House easily passed a one-week government-wide funding bill that sets a new Dec. 18 deadline for Congress to wrap up both the COVID-19 relief measure and a $1.4 trillion catchall spending bill that is also overdue. The 343-67 vote sent the one-week bill to the Senate, where its expected to easily pass before a deadline of midnight Friday to avert a partial government shutdown.

The measure would give lawmakers more time to sort through the hot mess they have created for themselves after months of futile negotiations and posturing and recent rounds of flip-flopping.

Top GOP leaders said the right people to handle endgame negotiations are the top four leaders of Congress and the Trump administration, focused on a proposal by Senate Majority Leader Mitch McConnell to eliminate a Democratic demand for a $160 billion or so aid package for state and local governments.

Read the full report here.

3:21 p.m. Lightfoot plans free vaccinations next year for all adults living, working in Chicago

Mayor Lori Lightfoot on Wednesday outlined plans to distribute free coronavirus vaccines next year to all adults who live and work in Chicago, beginning with front-line health care workers and employees of long-term care facilities, many of whom are minorities.

If Federal Drug Administration approval goes as planned Pfizers vaccine Thursday, Modernas next week the Chicago Department of Public Health expects to receive 23,000 doses later this month, with additional doses every week after that.

Were anticipating in the month of December somewhere in the 100,000-to-150,000 range. Were ready for twice that. Were ready for half that, Health Commissioner Dr. Allison Arwady told reporters.

During the first week, the vaccine will be distributed to Chicagos 34 hospitals to begin vaccinating highest-risk health care workers. That includes those treating COVID patients, or working in intensive care units.

During the second or third week, the city also anticipates rolling out vaccines to staff and residents at all 128 long-term care facilities in Chicago, including both skilled nursing and assisted care facilities.

In late December or early January, the city plans to open mass vaccination sites, by appointment only, for the remainder of the 400,000-strong universe of healthcare workers who are not based in hospitals.

As Illinois coronavirus numbers took another step in the right direction Tuesday, Gov J.B. Pritzker touted the promising early reviews of the COVID-19 vaccine that could start being administered to health care workers across the state as early as next week.

But with daily death counts stuck in the triple digits and a potential post-Thanksgiving spike still looming, the governor warned against complacency in the face of the deadly virus even with the vaccine in sight.

Once the U.S. Food and Drug Administration gives emergency use authorization to the Pfizer vaccine as expected Thursday, an independent state panel will also have to sign off for distribution in Illinois. But the governors health team made clear that the first shipment of the 95%-effective inoculation will be cast across Illinois in short order.

Illinois will only distribute a vaccine that is deemed safe, and we are one of many states that have established additional review panels, Pritzker said. We all want to make sure this vaccine is safe, and additional sets of eyes on the evidence can only be helpful.

Read the full story from Mitchell Armentrout here.

COLUMBUS, Ohio The Big Ten athletic directors support removing the conferences six-game minimum requirement for teams to be eligible to play for the league championship, and a vote is expected Wednesday to make it official.

Removing the minimum would clear the way for No. 3 Ohio State (5-0) to play in the Big Ten championship game on Dec. 19 against No. 15 Northwestern.

A person with knowledge of the Big Tens discussions told The Associated Press on Wednesday that before the rule can officially be changed it must be voted on by ADs, senior womens administrators and presidents.

The person spoke to the AP on condition of anonymity because the Big Ten was not making its internal discussions public.

The conference determined before the season that teams would have to play six of their eight scheduled games to qualify for the championship game. But Ohio State No. 4 in the College Football Playoff rankings and the conferences best team has missed three games because of COVID-19 issues, leaving it one short.

Read the full story here.

TORONTO Canadas health regulator on Wednesday approved Pfizers COVID-19 vaccine.

Health Canada posted on it is website that the vaccine made by U.S. drugmaker Pfizer and Germanys BioNTech is authorized.

Canadians can feel confident that the review process was rigorous and that we have strong monitoring systems in place. Health Canada and the Public Health Agency of Canada will closely monitor the safety of the vaccine once it is on the market and will not hesitate to take action if any safety concerns are identified, Health Canada said in a statement.

Canada is set to receive up to 249,000 doses this month and 4 million doses of the vaccine by March.

The department said the vaccine is for use in people 16 years of age or older, but noted Pfizer-BioNTech are running further clinical trials on children of all age groups and that could change.

Read the full story here.

LONDON British regulators warned Wednesday that people who have a history of serious allergic reactions shouldnt receive the new Pfizer-BioNTech vaccine as they investigate two adverse reactions that occurred on the first day of the countrys mass vaccination program.

The U.K.s Medical and Healthcare Products Regulatory Agency is looking into whether the reactions were linked to the vaccine. The two people affected were staff members with the National Health Service who had a history of allergies, and both are recovering. Authorities have not specified what their reactions were.

In the meantime, the regulator has issued the warning for anyone who has had a significant allergic reaction to a vaccine, medicine or food. That includes anyone who has been told to carry an adrenaline shot or others who have had potentially fatal allergic reactions.

As is common with new vaccines the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday, Professor Stephen Powis, medical director for the NHS in England, said in a statement. Both are recovering well.

Read the full story here.

The thing about death in the year 2020 is ... its not limited to COVID-19.

In the year of COVID, people you love make their transitions the same way socially distanced, with much time since you saw or even talked to them last, their passing a jolt to your isolation-addled consciousness, memories left to fade like beautiful ghosts.

And so it was this weekend, when news came of the passing of two beloved members of my church family, from cancer, on the same day, Dec. 3. Gloria Woods and Nathan Clark were also members of my smaller, close-knit sub-family, Evanston Area Black Catholics, Inc.

COVID has created a new lifestyle. We are isolated, adapting to executing our own everyday work and family obligations under the fears and anxiety 2020 has wrought.

COVID deaths occur in hospitals that are locked down by a coronavirus cloaked as the grim reaper. It shuts out loved ones and our opportunity to say goodbye.

But death is still our eventual destination, and COVID hasnt changed that.

Read the full story from Maudlyne Ihejirika here.

Xavier P. Gaines made his living as an armed security guard but loved working on computers and playing video games, dreaming he might one day have a chance to design his own games.

Gaines lived at home with his mom, kept to himself and stayed out of trouble. In fact, hed never been in any trouble.

Gaines was only 26 when he landed on this weeks Cook County medical examiners list of COVID-19 victims.

He died Dec. 2, his heart giving out as he struggled to breathe just moments after walking down the steps of his West Pullman home before he could get to the hospital.

He died in front of my house, in the ambulance, his mother, Nicky Reynolds, told me between tears.

Gaines was a big man. Maybe 6 foot tall, 365 to 375 pounds, his family said.

The Medical Examiners office listed morbid obesity as a contributing factor in his death.

Some families would prefer I gloss over that part, knowing that people can be judgmental. But the deadly coronavirus is particularly dangerous to those who are overweight, and Ive come across it often enough at this point to know its a factor that should be emphasized, not hidden.

Read the full column from Mark Brown here.

Last month, researchers in Texas estimated that nearly 5 million of the states residents had been infected by the COVID-19 virus more than four times as many as the official tally of confirmed cases suggested.

Although the gap implied that the virus was much less deadly than people initially feared, the Houston Chronicle framed the prevalence estimate as bad news.

That choice reflects a broader pattern in American press coverage of the pandemic, which tends to accentuate the negative, exaggerate risk and ignore encouraging information. The result is not just depressing but misleading and potentially counterproductive as Americans are told to keep up their guard against the virus during the winter they will have to get through before vaccines are widely available.

Based on an analysis of news stories about COVID-19 that appeared from Jan. 1 through July 31, Dartmouth economist Bruce Sacerdote and two other researchers found that 91% of the coverage by major U.S. media outlets was negative in tone. The rate was substantially lower in leading scientific journals (65%) and foreign news sources (54%).

Read the full column from Jacob Sullum here.

More here:

Illinois endures its fifth-highest daily death count ahead of coronavirus vaccines expected arrival (LIVE UP - Chicago Sun-Times

Explainer: What the UK cases of allergic reaction mean for Pfizer’s COVID-19 vaccine – Reuters

December 10, 2020

(Reuters) - Britains medicines regulator has advised people with a history of significant allergies not to get the Pfizer-BioNTech COVID-19 vaccine after two people reported adverse reactions on the first day of its rollout in the UK.

FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/File Photo

Here are some questions and answers about the cases and what they might mean.

UK officials said there have been two reports of anaphylaxis and one report of a possible allergic reaction since rollout began. Anaphylaxis can cause throat swelling, breathing trouble and difficulty swallowing, according to the American Academy of Allergy, Asthma & Immunology. Anaphylaxis is an overreaction of the bodys immune system, which the UK National Health Service describes as severe and sometimes life-threatening.

British regulators initially responded by saying anyone with a history of a significant allergic reaction to a vaccine, medicine or food should not take the shot. An adviser to the group later said it was tweaking advice in part to say a food allergy was not a risk.

Late on Wednesday, the UK regulator said anyone with a history of anaphylaxis to a vaccine, medicine or food should not get the vaccine.

Pfizer had excluded people with a history of significant adverse reaction to vaccines or its vaccines ingredients from late-stage trials.

U.S. regulators are expected to consider emergency authorization of the Pfizer vaccine soon after a Thursday meeting of advisers.

Moncef Slaoui, who is spearheading the U.S. governments vaccine development efforts, said on Wednesday he expected the British allergic reactions would be considered in the U.S. authorization process and that people with known severe allergic reactions probably should not take the vaccine until more was understood.

Some praised UK regulators caution, while others said broad restrictions were not warranted by available evidence.

For the general population, this does not mean that they would need to be anxious about receiving the vaccination, said Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine.

What would be wise, he said, would be for anyone who has known severe allergic reaction such that they need to carry an EpiPen to delay having a vaccination until the reason for the allergic reaction has been clarified.

Mayo Clinic virologist Gregory Poland, who has advised U.S. regulators, described Britains early reaction as overdoing it, pointing to the initial response about food allergies, which he said have nothing to do with this.

I would have said, If youve had anaphylactic-level reactions to vaccines, we want to know about that so we take extra care, he said. That doesnt mean I wouldnt immunize you. But I would do it in a more controlled setting.

Peter Openshaw, a professor of experimental medicine at Imperial College London, praised the way the reactions had been handled. The fact that we know so soon about these two allergic reactions and that the regulator has acted on this to issue precautionary advice shows that the monitoring system is working well, he said.

Mitchell Grayson, director of the division of allergy and immunology at Nationwide Childrens Hospital in Ohio, voiced concern over how the issue might reduce interest in vaccinations. Im worried the whole event will cause millions of people to choose not to get vaccinated because of what they heard, he said.

In the UK in 2012 there were around seven hospital admissions per 100,000 people for severe allergies. This included different triggers such as foods, drugs and insect stings, said Louisa James, a expert in immunology at Queen Mary University of London. Fatalities remain very rare and have not increased even as hospital admissions have risen in many countries.

Reporting by Kate Kelland and Alistair Smout in London, Julie Steenhuysen in Chicago, and Michael Erman in New Jersey and Carl ODonnell in New York; Editing by Peter Henderson, Tom Brown and Leslie Adler

Originally posted here:

Explainer: What the UK cases of allergic reaction mean for Pfizer's COVID-19 vaccine - Reuters

UK probing if allergic reactions linked to Pfizer vaccine – KARE11.com

December 10, 2020

The UK began vaccinating elderly people and medical workers with a vaccine developed by American drugmaker Pfizer and Germany's BioNTech, the world's first rollout.

LONDON, UK Britain's medical regulator warned Wednesday that people with a history of serious allergic reactions shouldnt receive the COVID-19 vaccine from Pfizer and BioNTech as investigators look into whether two reactions on the first day of the countrys vaccination program were linked to the shot.

Professor Stephen Powis, medical director for National Health Service in England, said the advice was issued on a precautionary basis and that the people who had reactions had recovered.

Pfizer and BioNTech said they were working with investigators to better understand each case and its causes.

In the meantime, the Medical and Healthcare Products Regulatory Agency has said people should not received the vaccine if they have had a significant allergic reaction to a vaccine, medicine or food, such as those who have been told to carry an adrenaline shot sometimes called EpiPens or others who have had potentially fatal allergic reactions. The medical regulator also said vaccinations should be carried out only in facilities that have resuscitation equipment.

Such advice isn't uncommon; several vaccines already on the market carry warnings about allergic reactions, and doctors know to watch for them when people whove had reactions to drugs or vaccines in the past are given new products.

The two people who reported reactions were NHS staff members who had a history of significant allergies and carried adrenaline shots. Both had serious reactions, but recovered after treatment, the NHS said.

Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine, said the regulator had done the right thing, but the general public shouldn't be worried about getting the vaccine.

For the general population, this does not mean that they would need to be anxious about receiving the vaccination," he said. One has to remember that even things like marmite can cause unexpected severe allergic reactions.

The warning comes just a day after Britain rolled out its mass vaccination programamid efforts to control a pandemic that has killed more than 62,000 people across the country. The MHRA gave an emergency authorization to the Pfizer-BioNtech vaccine last week, making Britain the first country to approve its widespread use. Canada's regulator authorized the vaccineWednesday.

Even in non-emergency situations, health authorities must closely monitor new vaccines and medications because studies in tens of thousands of people cant detect a rare risk that would affect 1 in 1 million. Authorities have not said how many people have received the shot in Britain so far, but they plan to give 800,000 doses in the first phase, which will target people over 80, nursing home staff and some NHS workers.

Late-stage trials of the vaccine found no serious safety concerns, Pfizer and BioNTech said. More than 42,000 people have received two doses of the shot during those trials.

Detailed data from the vaccine's trials showed potential allergic reactions in 0.63% of those who received the vaccine, compared with 0.51% of those who received the placebo. Reviewers from the U.S. Food and Drug Administration called this a slight numerical imbalance.

Documents published by the two companies showed that people with a history of severe allergic reactions were excluded from the trials, and doctors were advised to look out for such reactions in trial participants who werent previously known to have severe allergies.

As part of its emergency authorization for the vaccine, the MHRA required healthcare workers to report any adverse reactions to help regulators gather more information about safety and effectiveness.

The agency is monitoring the vaccine rollout closely and will now investigate these cases in more detail to understand if the allergic reactions were linked to the vaccine or were incidental, Powis said. The fact that we know so soon about these two allergic reactions and that the regulator has acted on this to issue precautionary advice shows that this monitoring system is working well.

Dr. June Raine, head of the medical regulatory agency, informed a Parliamentary committee about the reactions during previously scheduled testimony on the pandemic.

We know from the very extensive clinical trials that this wasnt a feature of the vaccine, she said. But if we need to strengthen our advice, now that we have had this experience in the vulnerable populations, the groups who have been selected as a priority, we get that advice to the field immediately.

See original here:

UK probing if allergic reactions linked to Pfizer vaccine - KARE11.com

What kinds of side effects could there be to a COVID-19 vaccine? – 11Alive.com WXIA

December 10, 2020

ATLANTA Getting back to normal and defeating the pandemic all comes down to a smooth roll-out of a vaccine.

But Georgia state health officials face a major hurdle getting people to trust the science.

An 11Alive-Survey USA Poll shows only 20 percent of people say they will definitely get a vaccine.

Thirty-six percent say they are very or somewhat likely, while 20 percent say it's unlikely, and 13 percent of Georgians say they will absolutely refuse to get vaccinated.

"I can say with great enthusiasm, I can't wait to get vaccinated," said Georgia Department of Public Health Commissioner Dr. Kathleen Toomey.

Toomey, the state's top health official, expressed total confidence in the safety of the vaccines on its way to Georgia and the importance of immunization.

"Because until we can vaccinate as many Georgians as possible, the level of immunity within the state, as a whole, to prevent continued spread," Toomey said.

The vaccines, one made by Moderna, the other by Pfizer -- each require two shots.

Pfizer's shots are administered 21 days apart, while Moderna's are given 28 days apart.

Both also are close to the same effectiveness -- about 95 percent.

The director of Public Health for Cobb and Douglas counties re-emphasized that achievement last week on YouTube.

"That means 94-to-95 percent of people who receive the vaccine, will not get COVID-19 if they are exposed to it," said Dr. Janet Memark. "So, that's very important that's a very high percentage and it means it is very effective."

High efficacy like that comes with likely mild side effects, similar to the flu shot, like a fever, arm soreness, and fatigue.

"I think that's something that we need to communicate about," Toomey said. "That's to be expected. That's not a complication. It's not a problem that needs to be worried about."

Visit link:

What kinds of side effects could there be to a COVID-19 vaccine? - 11Alive.com WXIA

JBLM among the first military bases to get COVID-19 vaccine – KING5.com

December 10, 2020

The DOD plans to administer its initial allocation of 43,875 doses of the COVID-19 vaccine to all the bases.

TACOMA, Wash. The Madigan Army Medical Center at Joint Base Lewis McChord (JBLM) will be among the first military bases in the country to get the coronavirus vaccine.

The U.S. Department of Defense (DOD) announced the vaccine distribution on Wednesday, and JBLM is one of a dozen bases first on the list.

The DOD plans to administer its initial allocation of 43,875 doses of the COVID-19 vaccine to all the bases. It's unknown how many vaccines JBLM will get.

Those who will be eligible to receive the vaccine include uniformed service members, dependents, the National Guard, retirees, and civilian employees.

Distribution will be conducted in phases. Due to the limited availability of initial vaccine doses, the first phase will distribute and administer vaccines at select locations.

Initial distribution sites were selected by the DODs COVID Task Force from sites recommended by the military services and U.S. Coast Guard.

JBLM was selected for its:

You can see the DOD's vaccinedistribution plan here.

Go here to read the rest:

JBLM among the first military bases to get COVID-19 vaccine - KING5.com

Page 252«..1020..251252253254..260270..»